Skip to main content

Reported Resistance Case(s)

Species: anopheles gambiae

Order Family Common Name(s) Group Host
diptera culicidae african malaria mosquito MED

Active Ingredient: BHC/cyclodienes - Unspecified In Literature

MOA: GABA-gated chloride channel antagonists, Cyclodiene organochlorines
Group: CYCLO CAS #: 0 Shaugnessy Code: 0

Resistance Case(s)

Case Id Year of Report Type of Resistance Location Reference
G3660 1980 Field Evolved Resistance
Zaire WHO 1980. (1980).
G3659 1980 Field Evolved Resistance
Madagascar WHO 1980. (1980).
G3070 1976 Field Evolved Resistance
Ghana WHO 1976. (1976).
G3078 1976 Field Evolved Resistance
Togo WHO 1976. (1976).
G3077 1976 Field Evolved Resistance
Sierra Leone WHO 1976. (1976).
G3076 1976 Field Evolved Resistance
Senegal WHO 1976. (1976).
G3075 1976 Field Evolved Resistance
Mauritania WHO 1976. (1976).
G3074 1976 Field Evolved Resistance
Mali WHO 1976. (1976).
G3073 1976 Field Evolved Resistance
Liberia WHO 1976. (1976).
G3072 1976 Field Evolved Resistance
Kenya WHO 1976. (1976).
G3071 1976 Field Evolved Resistance
Guinea WHO 1976. (1976).
G3069 1976 Field Evolved Resistance
Gambia WHO 1976. (1976).
G3068 1976 Field Evolved Resistance
Equatorial Guinea WHO 1976. (1976).
G3067 1976 Field Evolved Resistance
Cote d'Ivoire WHO 1976. (1976).
G3066 1976 Field Evolved Resistance
Congo WHO 1976. (1976).
G3065 1976 Field Evolved Resistance
Central African Republic WHO 1976. (1976).
G3064 1976 Field Evolved Resistance
Burkina Faso WHO 1976. (1976).
G3063 1976 Field Evolved Resistance
Benin WHO 1976. (1976).
G1106 1966 Field Evolved Resistance
Sudan WHO 1966a. (1966).
G287 1961 Field Evolved Resistance
Cameroon Gariou, J. and Mouchet, J. (1961). Apparition of a strain of Anopheles gambiae resistnat to dieldrin in the zone of the paludism campaign in Cameroon.. Bull. Soc. Path. Exot., 54 870-75.
G88 1956 Field Evolved Resistance
Nigeria Elliot, R. (1956). Insecticide resistance in Anopheles gambiae Giles.. Nature (Lond.), 177 532-33.
*The population was created solely by selection and/or genetic manipulation.
**The population was selected further in the laboratory after collection.